Fund Holdings — BML Capital Management, LLC

Total Portfolio Value
$149.36M
Total Bought
$40.36M
Total Sold
$21.56M
Net Transaction
+$18.80M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ADVERUM BIOTECHNOLOGIES INC0833,117+833,117011,7807.89%+11,780
ACLARIS THERAPEUTICS INC(ACRS)653,1079,395,934+8,742,82768611,6517.80%+10,965
ATEA PHARMACEUTICALS INC(AVIR)5,462,0795,536,710+74,63116,65922,36814.98%+5,709
INSTIL BIO INC(TIL)0348,735+348,73503,7662.52%+3,766
PMV PHARMACEUTICALS INC(PMVP)01,306,490+1,306,49002,2211.49%+2,221
RENEO PHARMACEUTICALS INC1,314,2292,177,913+863,6842,1033,6152.42%+1,513
LENZ THERAPEUTICS INC(LENZ)063,916+63,91601,4270.96%+1,427
CONNECT BIOPHARMA HLDGS LTD2,061,4382,061,338-1002,4323,5872.40%+1,154
CYTEIR THERAPEUTICS INC3,250,0083,654,053+404,0459,88010,9997.36%+1,119
DESIGN THERAPEUTICS INC(DSGN)1,029,478879,478-150,0002,7283,5442.37%+816
Q32 BIO INC(FIXX)024,894+24,89404240.28%+424
MILESTONE PHARMACEUTICALS IN(MIST)442,352606,145+163,7937391,0850.73%+346
NEXTCURE INC306,465306,46503496830.46%+334
CALCIMEDICA INC(CALC)145,424160,424+15,0004166670.45%+251
KINNATE BIOPHARMA INC468,210498,851+30,6411,1101,3270.89%+217
ENLIVEN THERAPEUTICS INC50,00050,100+1006928810.59%+189
LISATA THERAPEUTICS INC(LSTA)269,839284,669+14,8307378880.59%+152
ALLOVIR INC0200,464+200,46401510.10%+151
ELIEM THERAPEUTICS INC(CLYM)2,180,0002,193,742+13,7425,8866,0114.02%+125
ISHARES TR270,000270,000027,07327,19218.21%+119
ASTROTECH CORP220,410220,41001,8711,9731.32%+101
SPDR SER TR
ST STR BLO 1 ETF
200,000200,000018,27818,36012.29%+82
TALIS BIOMEDICAL CORP42,74342,74303183740.25%+56
ARCA BIOPHARMA INC706,930706,93001,2021,2440.83%+42
VISTAGEN THERAPEUTICS INC(VTGN)150,000150,00007717920.53%+21
FORTE BIOSCIENCES INC1,761,7021,761,70201,4481,2260.82%-221
VERRICA PHARMACEUTICALS INC(VRCA)180,000180,00001,3181,0660.71%-252
AVROBIO INC4,001,6274,001,62705,4425,1223.43%-320
ORAMED PHARMACEUTICALS INC(ORMP)1,261,559844,496-417,0632,9142,4661.65%-448
HOMOLOGY MEDICINES INC748,1080-748,1084550—-455
NEUROGENE INC(NGNE)24,6660-24,6664780—-478
ATHIRA PHARMA INC1,454,362900,000-554,3623,5342,4661.65%-1,068
GRAPHITE BIO INC447,4160-447,4161,1720—-1,172
RAIN ONCOLOGY INC1,349,0070-1,349,0071,6190—-1,619
ADVERUM BIOTECHNOLOGIES INC4,554,2520-4,554,2523,4280—-3,428
THESEUS PHARMACEUTICALS INC1,108,3200-1,108,3204,4890—-4,489
TOURMALINE BIO INC245,5000-245,5006,4270—-6,427
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q1 2024 | TickerTrail